Читать книгу Cases in Medical Microbiology and Infectious Diseases - Melissa B. Miller - Страница 66

1. Guiso N. 2009. Bordetella pertussis and pertussis vaccines. Clin Infect Dis 49:1565–1569.

2. Klein NP, Bartlett J, Rowhani-Rahbar A, Fireman B, Baxter R. 2012. Waning protection after fifth dose of acellular pertussis vaccine in children. N Engl J Med 367:1012–1019.

3. Loeffelholz M. 2012. Towards improved accuracy of Bordetella pertussis nucleic acid amplification tests. J Clin Microbiol 50:2186–2190.

4. Mandal S, Tatti KM, Woods-Stout D, Cassiday PK, Faulkner AE, Griffith MM, Jackson ML, Pawloski LC, Wagner B, Barnes M, Cohn AC, Gershman KA, Messonnier NE, Clark TA, Tondella ML, Martin SW. 2012. Pertussis pseudo-outbreak linked to specimens contaminated by Bordetella pertussis DNA from clinic surfaces. Pediatrics 129:e424–e430.

5. Murphy TV, Slade BA, Broder KR, Kretsinger K, Tiwari T, Joyce PM, Iskander JK, Brown K, Moran JS; Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). 2008. Prevention of pertussis, tetanus, and diphtheria among pregnant and postpartum women and their infants; recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 57:1–51.

6. Wood N, McIntyre P. 2008. Pertussis: review of epidemiology, diagnosis, management and prevention. Paediatr Respir Rev 9:201–212.